Pulmonary atresia is a congenital heart defect where the pulmonary valve does not form properly, obstructing blood flow from the heart to the lungs. The ICD-10 code for pulmonary atresia is Q25.4. In the older ICD-9 code system, pulmonary atresia is represented by code 746.01. These codes are used for medical billing, research, and documentation purposes to classify and identify specific conditions.
Pulmonary atresia is a rare congenital heart defect characterized by the absence or severe narrowing of the pulmonary valve. This condition results in the inadequate flow of blood from the right ventricle to the lungs, leading to various complications. In the International Classification of Diseases, 10th Revision (ICD-10), pulmonary atresia is classified under the code Q22.1.
ICD-10 is a standardized system used worldwide to classify and code diseases, disorders, and other health conditions. It provides a comprehensive framework for healthcare professionals to accurately document and communicate diagnoses. The code Q22.1 specifically represents "Congenital pulmonary valve atresia," enabling medical practitioners to easily identify and track cases of this particular condition.
In contrast, the International Classification of Diseases, 9th Revision (ICD-9) was the previous version of this coding system. The ICD-9 code for pulmonary atresia is 746.01. This code falls under the broader category of "Congenital anomalies of heart," allowing healthcare providers to classify and document this specific heart defect in their patients.
By utilizing these standardized codes, healthcare professionals can effectively communicate and share information about patients' diagnoses, enabling accurate tracking, research, and appropriate treatment planning. These codes play a crucial role in streamlining healthcare processes and ensuring consistent and comprehensive medical documentation.